Abbott Laboratories’ AbbVie hit Amneal Pharmaceuticals with a patent suit in Delaware Federal Court, arguing that Amneal has infringed a patent covering its cholesterol medication, Niaspan.
Law360
Law360
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
FDA Offers Suggestions for Labeling Vasculature Devices with Lubricious Coatings
The FDA recommends that labeling includes a statement identifying whether or not the device is coated.
FDA Issues Recommendations for Developing Epidermolysis Bullosa Drugs
The agency said trials should demonstrate a clinically meaningful improvement in at least one sign or symptom.